目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Asthma - Market size and forecast 2021-2026
Exhibit 28: Chart on Asthma - Market size and forecast 2021-2026 ($ billion)
Exhibit 29: Data Table on Asthma - Market size and forecast 2021-2026 ($ billion)
Exhibit 30: Chart on Asthma - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Asthma - Year-over-year growth 2021-2026 (%)
5.4 COPD - Market size and forecast 2021-2026
Exhibit 32: Chart on COPD - Market size and forecast 2021-2026 ($ billion)
Exhibit 33: Data Table on COPD - Market size and forecast 2021-2026 ($ billion)
Exhibit 34: Chart on COPD - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on COPD - Year-over-year growth 2021-2026 (%)
5.5 Allergic rhinitis - Market size and forecast 2021-2026
Exhibit 36: Chart on Allergic rhinitis - Market size and forecast 2021-2026 ($ billion)
Exhibit 37: Data Table on Allergic rhinitis - Market size and forecast 2021-2026 ($ billion)
Exhibit 38: Chart on Allergic rhinitis - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Allergic rhinitis - Year-over-year growth 2021-2026 (%)
5.6 Cystic fibrosis - Market size and forecast 2021-2026
Exhibit 40: Chart on Cystic fibrosis - Market size and forecast 2021-2026 ($ billion)
Exhibit 41: Data Table on Cystic fibrosis - Market size and forecast 2021-2026 ($ billion)
Exhibit 42: Chart on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
5.7 Other respiratory diseases - Market size and forecast 2021-2026
Exhibit 44: Chart on Other respiratory diseases - Market size and forecast 2021-2026 ($ billion)
Exhibit 45: Data Table on Other respiratory diseases - Market size and forecast 2021-2026 ($ billion)
Exhibit 46: Chart on Other respiratory diseases - Year-over-year growth 2021-2026 (%)
Exhibit 47: Data Table on Other respiratory diseases - Year-over-year growth 2021-2026 (%)
5.8 Market opportunity by Type
Exhibit 48: Market opportunity by Type ($ billion)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 52: Chart on Geographic comparison
Exhibit 53: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 90: Market opportunity By Geographical Landscape ($ billion)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 91: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 93: Overview on factors of disruption
9.4 Industry risks
Exhibit 94: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 95: Vendors covered
10.2 Market positioning of vendors
Exhibit 96: Matrix on vendor position and classification
10.3 Abbott Laboratories
Exhibit 97: Abbott Laboratories - Overview
Exhibit 98: Abbott Laboratories - Business segments
Exhibit 99: Abbott Laboratories - Key news
Exhibit 100: Abbott Laboratories - Key offerings
Exhibit 101: Abbott Laboratories - Segment focus
10.4 AstraZeneca Plc
Exhibit 102: AstraZeneca Plc - Overview
Exhibit 103: AstraZeneca Plc - Product / Service
Exhibit 104: AstraZeneca Plc - Key news
Exhibit 105: AstraZeneca Plc - Key offerings
10.5 Boehringer Ingelheim International GmbH
Exhibit 106: Boehringer Ingelheim International GmbH - Overview
Exhibit 107: Boehringer Ingelheim International GmbH - Business segments
Exhibit 108: Boehringer Ingelheim International GmbH - Key news
Exhibit 109: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 110: Boehringer Ingelheim International GmbH - Segment focus
10.6 Celon Pharma SA
Exhibit 111: Celon Pharma SA - Overview
Exhibit 112: Celon Pharma SA - Business segments
Exhibit 113: Celon Pharma SA - Key offerings
Exhibit 114: Celon Pharma SA - Segment focus
10.7 F. Hoffmann La Roche Ltd.
Exhibit 115: F. Hoffmann La Roche Ltd. - Overview
Exhibit 116: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 117: F. Hoffmann La Roche Ltd. - Key news
Exhibit 118: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 119: F. Hoffmann La Roche Ltd. - Segment focus
10.8 GlaxoSmithKline Plc
Exhibit 120: GlaxoSmithKline Plc - Overview
Exhibit 121: GlaxoSmithKline Plc - Business segments
Exhibit 122: GlaxoSmithKline Plc - Key news
Exhibit 123: GlaxoSmithKline Plc - Key offerings
Exhibit 124: GlaxoSmithKline Plc - Segment focus
10.9 Glenmark Pharmaceuticals Ltd.
Exhibit 125: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 126: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 127: Glenmark Pharmaceuticals Ltd. - Key offerings
10.10 Novartis AG
Exhibit 128: Novartis AG - Overview
Exhibit 129: Novartis AG - Business segments
Exhibit 130: Novartis AG - Key offerings
Exhibit 131: Novartis AG - Segment focus
10.11 Teva Pharmaceutical Industries Ltd.
Exhibit 132: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 133: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 134: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 135: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 136: Teva Pharmaceutical Industries Ltd. - Segment focus
10.12 Vertex Pharmaceuticals Inc.
Exhibit 137: Vertex Pharmaceuticals Inc. - Overview
Exhibit 138: Vertex Pharmaceuticals Inc. - Product / Service
Exhibit 139: Vertex Pharmaceuticals Inc. - Key offerings

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 140: Inclusions checklist
Exhibit 141: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 142: Currency conversion rates for US$
11.4 Research methodology
Exhibit 143: Research methodology
Exhibit 144: Validation techniques employed for market sizing
Exhibit 145: Information sources
11.5 List of abbreviations
Exhibit 146: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Asthma - Market size and forecast 2021-2026 ($ billion)
Exhibits29: Data Table on Asthma - Market size and forecast 2021-2026 ($ billion)
Exhibits30: Chart on Asthma - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Asthma - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on COPD - Market size and forecast 2021-2026 ($ billion)
Exhibits33: Data Table on COPD - Market size and forecast 2021-2026 ($ billion)
Exhibits34: Chart on COPD - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on COPD - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Allergic rhinitis - Market size and forecast 2021-2026 ($ billion)
Exhibits37: Data Table on Allergic rhinitis - Market size and forecast 2021-2026 ($ billion)
Exhibits38: Chart on Allergic rhinitis - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Allergic rhinitis - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Cystic fibrosis - Market size and forecast 2021-2026 ($ billion)
Exhibits41: Data Table on Cystic fibrosis - Market size and forecast 2021-2026 ($ billion)
Exhibits42: Chart on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
Exhibits44: Chart on Other respiratory diseases - Market size and forecast 2021-2026 ($ billion)
Exhibits45: Data Table on Other respiratory diseases - Market size and forecast 2021-2026 ($ billion)
Exhibits46: Chart on Other respiratory diseases - Year-over-year growth 2021-2026 (%)
Exhibits47: Data Table on Other respiratory diseases - Year-over-year growth 2021-2026 (%)
Exhibits48: Market opportunity by Type ($ billion)
Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits52: Chart on Geographic comparison
Exhibits53: Data Table on Geographic comparison
Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits88: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ billion)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Abbott Laboratories - Overview
Exhibits98: Abbott Laboratories - Business segments
Exhibits99: Abbott Laboratories - Key news
Exhibits100: Abbott Laboratories - Key offerings
Exhibits101: Abbott Laboratories - Segment focus
Exhibits102: AstraZeneca Plc - Overview
Exhibits103: AstraZeneca Plc - Product / Service
Exhibits104: AstraZeneca Plc - Key news
Exhibits105: AstraZeneca Plc - Key offerings
Exhibits106: Boehringer Ingelheim International GmbH - Overview
Exhibits107: Boehringer Ingelheim International GmbH - Business segments
Exhibits108: Boehringer Ingelheim International GmbH - Key news
Exhibits109: Boehringer Ingelheim International GmbH - Key offerings
Exhibits110: Boehringer Ingelheim International GmbH - Segment focus
Exhibits111: Celon Pharma SA - Overview
Exhibits112: Celon Pharma SA - Business segments
Exhibits113: Celon Pharma SA - Key offerings
Exhibits114: Celon Pharma SA - Segment focus
Exhibits115: F. Hoffmann La Roche Ltd. - Overview
Exhibits116: F. Hoffmann La Roche Ltd. - Business segments
Exhibits117: F. Hoffmann La Roche Ltd. - Key news
Exhibits118: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits119: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits120: GlaxoSmithKline Plc - Overview
Exhibits121: GlaxoSmithKline Plc - Business segments
Exhibits122: GlaxoSmithKline Plc - Key news
Exhibits123: GlaxoSmithKline Plc - Key offerings
Exhibits124: GlaxoSmithKline Plc - Segment focus
Exhibits125: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits126: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits127: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits128: Novartis AG - Overview
Exhibits129: Novartis AG - Business segments
Exhibits130: Novartis AG - Key offerings
Exhibits131: Novartis AG - Segment focus
Exhibits132: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits133: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits134: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits135: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits136: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits137: Vertex Pharmaceuticals Inc. - Overview
Exhibits138: Vertex Pharmaceuticals Inc. - Product / Service
Exhibits139: Vertex Pharmaceuticals Inc. - Key offerings
Exhibits140: Inclusions checklist
Exhibits141: Exclusions checklist
Exhibits142: Currency conversion rates for US$
Exhibits143: Research methodology
Exhibits144: Validation techniques employed for market sizing
Exhibits145: Information sources
Exhibits146: List of abbreviations